NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|51338813|sp|Q92837|]
View 

RecName: Full=Proto-oncogene FRAT1; AltName: Full=Frequently rearranged in advanced T-cell lymphomas 1; Short=FRAT-1

Protein Classification

GSK-3_bind domain-containing protein( domain architecture ID 10526546)

GSK-3_bind domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
GSK-3_bind pfam05350
Glycogen synthase kinase-3 binding; Glycogen synthase kinase-3 (GSK-3) sequentially ...
1-239 8.25e-116

Glycogen synthase kinase-3 binding; Glycogen synthase kinase-3 (GSK-3) sequentially phosphorylates four serine residues on glycogen synthase (GS), in the sequence SxxxSxxxSxxx-SxxxS(p), by recognising and phosphorylating the first serine in the sequence motif SxxxS(P) (where S(p) represents a phosphoserine). Interaction of GSK-3 with a peptide derived from GSK-3 binding protein (this family) prevents GSK-3 interaction with Axin. This interaction thereby inhibits the Axin-dependent phosphorylation of beta-catenin by GSK-3.


:

Pssm-ID: 428435  Cd Length: 237  Bit Score: 332.30  E-value: 8.25e-116
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 51338813     1 MPCRREEEEEAGEEAEGEEEEeDSFLLLQQSVALGSSGEVDRLVAQIGETLQLDAAQHSPASPCGPPGAPLRAPGPLAAa 80
Cdd:pfam05350   1 MPCRREEEEEAGEEAEGEEED-DSFLLLQQSVTLGSSGEVDRLVAQIGETLQLDAAQDSPASPCAPPGPPLRPPRPLAA- 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 51338813    81 VPADKARSPAVPLLLPPALAETVGPAPPGVLRCALGDRGRVRGRAAPYCVAELATGPSALSPLPPQADLDGPPGAGKQGI 160
Cdd:pfam05350  79 VPADKARSPARPLLLPPASAETGGPAPPGALRCALGDRGRVRGRAAPYCVAELAAGPSALSPLPPQPGLDGPPGAGKQGI 158
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 51338813   161 PQPLSGPCRRGWLRGAAASRRLQQRRGSQPETRTGDDDPHRLLQQLVLSGNLIKEAVRRLHSRRLQLRAKLPQRPLLGP 239
Cdd:pfam05350 159 PQPLSGPCRRGWLRGAAASRRLQQRRGSQPETRTGDDDPHRLLQQLVLSGNLIKEAVRRLHSRRLQLHAKLPQHPLLGP 237
 
Name Accession Description Interval E-value
GSK-3_bind pfam05350
Glycogen synthase kinase-3 binding; Glycogen synthase kinase-3 (GSK-3) sequentially ...
1-239 8.25e-116

Glycogen synthase kinase-3 binding; Glycogen synthase kinase-3 (GSK-3) sequentially phosphorylates four serine residues on glycogen synthase (GS), in the sequence SxxxSxxxSxxx-SxxxS(p), by recognising and phosphorylating the first serine in the sequence motif SxxxS(P) (where S(p) represents a phosphoserine). Interaction of GSK-3 with a peptide derived from GSK-3 binding protein (this family) prevents GSK-3 interaction with Axin. This interaction thereby inhibits the Axin-dependent phosphorylation of beta-catenin by GSK-3.


Pssm-ID: 428435  Cd Length: 237  Bit Score: 332.30  E-value: 8.25e-116
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 51338813     1 MPCRREEEEEAGEEAEGEEEEeDSFLLLQQSVALGSSGEVDRLVAQIGETLQLDAAQHSPASPCGPPGAPLRAPGPLAAa 80
Cdd:pfam05350   1 MPCRREEEEEAGEEAEGEEED-DSFLLLQQSVTLGSSGEVDRLVAQIGETLQLDAAQDSPASPCAPPGPPLRPPRPLAA- 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 51338813    81 VPADKARSPAVPLLLPPALAETVGPAPPGVLRCALGDRGRVRGRAAPYCVAELATGPSALSPLPPQADLDGPPGAGKQGI 160
Cdd:pfam05350  79 VPADKARSPARPLLLPPASAETGGPAPPGALRCALGDRGRVRGRAAPYCVAELAAGPSALSPLPPQPGLDGPPGAGKQGI 158
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 51338813   161 PQPLSGPCRRGWLRGAAASRRLQQRRGSQPETRTGDDDPHRLLQQLVLSGNLIKEAVRRLHSRRLQLRAKLPQRPLLGP 239
Cdd:pfam05350 159 PQPLSGPCRRGWLRGAAASRRLQQRRGSQPETRTGDDDPHRLLQQLVLSGNLIKEAVRRLHSRRLQLHAKLPQHPLLGP 237
 
Name Accession Description Interval E-value
GSK-3_bind pfam05350
Glycogen synthase kinase-3 binding; Glycogen synthase kinase-3 (GSK-3) sequentially ...
1-239 8.25e-116

Glycogen synthase kinase-3 binding; Glycogen synthase kinase-3 (GSK-3) sequentially phosphorylates four serine residues on glycogen synthase (GS), in the sequence SxxxSxxxSxxx-SxxxS(p), by recognising and phosphorylating the first serine in the sequence motif SxxxS(P) (where S(p) represents a phosphoserine). Interaction of GSK-3 with a peptide derived from GSK-3 binding protein (this family) prevents GSK-3 interaction with Axin. This interaction thereby inhibits the Axin-dependent phosphorylation of beta-catenin by GSK-3.


Pssm-ID: 428435  Cd Length: 237  Bit Score: 332.30  E-value: 8.25e-116
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 51338813     1 MPCRREEEEEAGEEAEGEEEEeDSFLLLQQSVALGSSGEVDRLVAQIGETLQLDAAQHSPASPCGPPGAPLRAPGPLAAa 80
Cdd:pfam05350   1 MPCRREEEEEAGEEAEGEEED-DSFLLLQQSVTLGSSGEVDRLVAQIGETLQLDAAQDSPASPCAPPGPPLRPPRPLAA- 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 51338813    81 VPADKARSPAVPLLLPPALAETVGPAPPGVLRCALGDRGRVRGRAAPYCVAELATGPSALSPLPPQADLDGPPGAGKQGI 160
Cdd:pfam05350  79 VPADKARSPARPLLLPPASAETGGPAPPGALRCALGDRGRVRGRAAPYCVAELAAGPSALSPLPPQPGLDGPPGAGKQGI 158
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 51338813   161 PQPLSGPCRRGWLRGAAASRRLQQRRGSQPETRTGDDDPHRLLQQLVLSGNLIKEAVRRLHSRRLQLRAKLPQRPLLGP 239
Cdd:pfam05350 159 PQPLSGPCRRGWLRGAAASRRLQQRRGSQPETRTGDDDPHRLLQQLVLSGNLIKEAVRRLHSRRLQLHAKLPQHPLLGP 237
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH